Breaking News

Couple uses ALS diagnosis to create a political juggernaut; 13 big questions about Biden’s Omicron response

    

 

Daily Recap

'I'm going to prove you wrong': How a D.C. power couple used an ALS diagnosis to create a political juggernaut

By Lev Facher

Kristen Norman for STAT

A devastating diagnosis. A fight against time. And an 'epic' journey that galvanized a new movement for ALS patients.

Read More

13 big questions about Biden's response to Omicron, as Congress prepares to grill Fauci, Walensky, and other top officials

By Andrew Joseph and Helen Branswell and Nicholas Florko and Lev Facher

Jon Cherry/Getty Images

A hearing today gives senators a chance to grill top Biden officials about the state of the pandemic and problems in the U.S. response.

Read More

STAT+: Amgen, Arrakis Therapeutics partner to develop oral drugs that eliminate troublesome RNA

By Adam Feuerstein

Adobe

Called “targeted RNA degraders,” this emerging technology will go after targets that traditional drug-development methods can’t reach.

Read More

Opinion: You'd expect health care workers on the Covid frontlines to be tested regularly. You'd be wrong

By Orly Nadell Farber

JOSEPH PREZIOSO/AFP via Getty Images

Health care workers are among those at very high risk of exposure to Covid-19. Why isn't Covid testing a routine part of their work?

Read More

Opinion: AMA's new language guide is a step toward health equity

By David Ansell and Vinoo Dissanayake

Adobe

The American Medical Association's new language guide encourages doctors to address the upstream social causes of health inequities.

Read More

Opinion: Active surveillance for prostate cancer: The gift that keeps on giving

By Howard Wolinsky

Adobe

For men with low-risk prostate cancer, active surveillance can be a good alternative to surgery or radiation therapy.

Read More

Tuesday, January 11, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments